Discover how maintenance therapy improves transplant outcomes for high-risk AML patients, with key insights from EBMT 2025.

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...

The 33-year-old started noticing something ‘wasn’t quite correct’ while competing in the Half Ironman World Championship in ...

A woman who visited hospital with toothache was given a heartbreaking diagnosis, leading her to being asked if she would ...

Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...